Definitions
Sorry, no definitions found. You may find more data at biopharma.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Biopharma.
Examples
-
Influenza Vaccine, H5N1/GSK - biopharma. com Biopharma product database - 208.69.231.70 EMERGENCY
WN.com - Articles related to Woman dies from bird flu infection in C China 2010
-
European Markets - www. biopharma.com Chemical Index - www. biopharma.com Biological Index - www. biopharma.com 393 Influenza Vaccine, H5N1/GSK - biopharma. com Biopharma product database -
WN.com - Articles related to 3 Mid-Western districts at bird flu risk 2010
-
NURENBERG: The president of a company called Biopharma sees eventual use of viruses in humans to fight disease and infections.
-
Also showing relative strength are biotechnology shares, up on the day by about 1.4% as a group, led by Ambrilia Biopharma, trading higher by about 50% and Pharmathene, trading higher by about 46.1% on Monday.
School Stocks Get The Dead Cat Bounce MarketNewsVideo.com 2010
-
A year ago, Amgen Ventures was one of five funds including Eli Lilly & Co.'s Lilly Ventures to invest in a $36.5 million round of funding for South San Francisco's Sutro Biopharma.
SFGate: Don Asmussen: Bad Reporter Ryan Flinn 2011
-
Under the terms of the five-year cooperative research and development agreement, Genesis Biopharma will work with Steven A. Rosenberg, M.D., Ph.D., the NCI Surgery Branch Chief, to develop adoptive cell immunotherapies that are designed to destroy metastatic melanoma cells using a patient's tumor infiltrating lymphocytes.
unknown title 2011
-
Biopharma's dirty secret revealed: science is fragile; forecasting is unreliable.
Forbes.com: News David Shaywitz 2012
-
Genesis Biopharma, Inc. is a development-stage biotechnology company engaged in the development of targeted cancer immunotherapies.
unknown title 2011
-
Business -- Biopharma developing targeted therapies for the treatment of cancer and inflammatory diseases.
unknown title 2011
-
Christopher Marlett, chief executive officer of MDB Capital Group commented by saying, RegeneRx Biopharma's imbedded IP value and demonstrated innovation places it in the top 10% of the approximately 1500 technology companies trading below $500 million in market value as ranked by our proprietary IP intelligence database called PatentVest.
unknown title 2011
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.